Clinical trial
A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers
NCT00414999 · TargeGen, Industry · Completed
Key facts
| NCT number | NCT00414999 |
|---|---|
| Title | A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers |
| Official title | A Phase 1, Double-Masked, Placebo-Controlled, Dose-Escalation Study (in Two Parts) of TG100801 and a Colored Vehicle in Adult Healthy Volunteers |
| Lead sponsor | TargeGen, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Macular Degeneration, Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | TG100801 |
| Enrollment | 44 |
| Start date | Nov 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Dec 22, 2006 |
| Last update posted | Jul 30, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: